Stocktoria
Rafael Holdings, Inc. RFL
NYSE · stock · Pharmaceutical Preparations · website · IPO 2018-03-12
Rafael Holdings, Inc. statistics & valuation
Market cap$143.6M
P / B1.5×
Net margin-3328.2%
Return on equity-31.0%
FCF margin-2064.1%
Return on capital-28.4%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -3179.8% | -16111.0% | -5391.8% | -14750.5% | -3516.1% | -172.4% | -135.8% | -87.9% | 3.9% |
| Net margin | -3328.2% | -5401.9% | -672.4% | -30404.4% | -2875.4% | -219.0% | -95.2% | -266.5% | 2.5% |
| FCF margin | -2064.1% | -1247.3% | — | -6361.2% | -1970.9% | -105.9% | -71.6% | -57.8% | -61.3% |
| Return on assets | -26.7% | -35.5% | -1.9% | -105.4% | -15.0% | -7.9% | -3.3% | -10.0% | 0.2% |
| Return on equity | -31.0% | -39.9% | -1.9% | -124.0% | -16.9% | -8.2% | -3.8% | -10.0% | 0.2% |
| Current ratio | 4.89 | 9.65 | 38.67 | 5.15 | 0.85 | 1.72 | 9.29 | 49.96 | 33.52 |
Computed from company filings · US · as of 2025-07-31. Facts plus Stocktoria's own computed scores — not investment advice.